Recro Pharma, Inc. (REPH)

[tjguy]

It's time for REPH to shine again!

Phase III results for Meloxicam are due to be reported in both the third and fourth quarter of this year.

If positive - and there is NO reason to think they will not be - this stock will see new highs relatively quickly.

Meloxicam if approved next year, should give the company a 500 million dollar market cap. Right now it stands at a mere $75 million so upside for the next 12 months is over 500%. Not sure if the 500 million market cap would be realized immediately upon approval or not - probably would take a bit longer, but once meloxicam begins to grab a market share, the market cap will rise significantly.

Maybe 500% within a year is too high, but certainly will be 3-4X with FDA approval which could come in a year.

Now is the time to get in!

I am long REPH, although my position is small. Wish I had a lot of free funds to invest. Oh well. Start where you are at and build.